AJP - Lung Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (October 17, 2008). doi:10.1152/ajplung.00026.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/1/L30    most recent
00026.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshioka, M.
Right arrow Articles by Takahashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshioka, M.
Right arrow Articles by Takahashi, K.
Submitted on January 14, 2008
Accepted on October 14, 2008

Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammation

Masakata Yoshioka1*, Hironori Sagara2, Fumiyuki Takahashi1, Norihiro Harada1, Kazuto Nishio3, Akio Mori4, Hiroko Ushio5, Kazue Shimizu1, Takenori Okada2, Mayumi Ota2, Yoichi M Ito6, Osamu Nagashima1, Ryo Atsuta1, Toshihiro Suzuki7, Takeshi Fukuda2, Yoshinosuke Fukuchi1, and Kazuhisa Takahashi1

1 Respiratory Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
2 Pulmonary Medicine and Clinical Immunology, Dokkyo University, School of Medicine, Mibu, Tochigi, Japan
3 Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan
4 Clinical Research Center for Allergy and Reumatology, National Sagamihara Hospital, Sagamihara, Kanagawa, Japan
5 Atopy Resarch Center, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
6 Biostatistics, The University of Tokyo, School of Pubulic Health, Bunkyo-ku, Tokyo, Japan
7 Analytical Biochemistry, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: seigo{at}juntendo.ac.jp.

Multidrug resistance-associated protein 1 (MRP1) is a cysteinyl leukotrienes (CysLTs)-export pump expressed on mast cells. CysLTs are crucial mediators in allergic airway disease. However, biological significance of MRP1 in allergic airway inflammation has not yet been elucidated. In this study, we sensitized wild-type control mice (mrp1+/+) and MRP1 deficient mice (mrp1-/-) to ovalbumin (OVA) and challenged them with OVA by aerosol. Airway inflammation and goblet cell hyperplasia after OVA exposure were reduced in mrp1-/- mice as compared with mrp1+/+ mice. Furthermore, CysLTs levels in bronchoalveolar lavage fluid (BALF) from OVA-exposed mrp1-/- mice were significantly lower than those from OVA-exposed mrp1+/+ mice. Levels of OVA-specific IgE, IL-4, and IL-13 in BALF were also decreased in OVA-exposed mrp1-/- mice. IgE-mediated release of CysLTs from murine bone marrow-derived mast cells were markedly impaired by MRP1-deficiency. Our results indicate that MRP1 plays an important role in the development of allergic airway inflammation through regulation of IgE-mediated CysLTs export from mast cells.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.